Saltar al contenido
Merck

No Overt Deficits in Aged Tau-Deficient C57Bl/6.Mapttm1(EGFP)Kit GFP Knockin Mice.

PloS one (2016-10-14)
Annika van Hummel, Mian Bi, Stefania Ippati, Julia van der Hoven, Alexander Volkerling, Wei S Lee, Daniel C S Tan, Andre Bongers, Arne Ittner, Yazi D Ke, Lars M Ittner
RESUMEN

Several mouse lines with knockout of the tau-encoding MAPT gene have been reported in the past; they received recent attention due to reports that tau reduction prevented Aβ-induced deficits in mouse models of Alzheimer's disease. However, the effects of long-term depletion of tau in vivo remained controversial. Here, we used the tau-deficient GFP knockin line Mapttm1(EGFP)kit on a pure C57Bl/6 background and subjected a large cohort of males and females to a range of motor, memory and behavior tests and imaging analysis, at the advanced age of over 16 months. Neither heterozygous nor homozygous Mapttm1(EGFP)kit mice presented with deficits or abnormalities compared to wild-type littermates. Differences to reports using other tau knockout models may be due to different genetic backgrounds, respective gene targeting strategies or other confounding factors, such as nutrition. To this end, we report no functional or morphological deficits upon tau reduction or depletion in aged mice.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Anticuerpo anti-gliceraldehído-3-fosfato deshidrogenasa, clon 6C5, clone 6C5, Chemicon®, from mouse
Sigma-Aldrich
Anticuerpo anti-proteína de densidad postsináptica 95, clon 6G6-1C9, clone 6G6-1C9, Chemicon®, from mouse
Sigma-Aldrich
Anticuerpo anti-NMDAR1 , clon 54.1, clone 54.1, Chemicon®, from mouse
Sigma-Aldrich
Anti-NMDAR2B Antibody, pain, serum, Chemicon®